Darolutamide Now Approved as Single Agent for MCSPC ...Middle East

Medscape - News
Darolutamide Now Approved as Single Agent for MCSPC
The FDA approval is based on safety and efficacy demonstrated in the phase 3 ARANOTE trial, which evaluated darolutamide — without docetaxel chemotherapy — vs placebo. Medscape Medical News

Hence then, the article about darolutamide now approved as single agent for mcspc was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Darolutamide Now Approved as Single Agent for MCSPC )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News